Bangladesh · Delayed Price · Currency is BDT Silco Pharmaceuticals Statistics
Total Valuation
DSE:SILCOPHL has a market cap or net worth of BDT 2.16 billion. The enterprise value is 2.13 billion.
| Market Cap | 2.16B |
| Enterprise Value | 2.13B |
Important Dates
The next estimated earnings date is Tuesday, December 8, 2026.
| Earnings Date | Dec 8, 2026 |
| Ex-Dividend Date | Dec 17, 2025 |
Share Statistics
DSE:SILCOPHL has 103.81 million shares outstanding. The number of shares has increased by 0.31% in one year.
| Current Share Class | 103.81M |
| Shares Outstanding | 103.81M |
| Shares Change (YoY) | +0.31% |
| Shares Change (QoQ) | +5.78% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 62.86.
| PE Ratio | 62.86 |
| Forward PE | n/a |
| PS Ratio | 5.28 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | 125.43 |
| P/OCF Ratio | 29.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.63, with an EV/FCF ratio of 123.85.
| EV / Earnings | 62.29 |
| EV / Sales | 5.22 |
| EV / EBITDA | 13.63 |
| EV / EBIT | 31.82 |
| EV / FCF | 123.85 |
Financial Position
The company has a current ratio of 4.81, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.81 |
| Quick Ratio | 2.10 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.07 |
| Interest Coverage | 138.96 |
Financial Efficiency
Return on equity (ROE) is 1.42% and return on invested capital (ROIC) is 1.43%.
| Return on Equity (ROE) | 1.42% |
| Return on Assets (ROA) | 1.48% |
| Return on Invested Capital (ROIC) | 1.43% |
| Return on Capital Employed (ROCE) | 2.61% |
| Weighted Average Cost of Capital (WACC) | 5.65% |
| Revenue Per Employee | 1.31M |
| Profits Per Employee | 109,352 |
| Employee Count | 313 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 0.58 |
Taxes
In the past 12 months, DSE:SILCOPHL has paid 32.94 million in taxes.
| Income Tax | 32.94M |
| Effective Tax Rate | 49.04% |
Stock Price Statistics
The stock price has increased by +51.06% in the last 52 weeks. The beta is 0.25, so DSE:SILCOPHL's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +51.06% |
| 50-Day Moving Average | 16.28 |
| 200-Day Moving Average | 14.94 |
| Relative Strength Index (RSI) | 70.63 |
| Average Volume (20 Days) | 2,692,582 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DSE:SILCOPHL had revenue of BDT 408.71 million and earned 34.23 million in profits. Earnings per share was 0.33.
| Revenue | 408.71M |
| Gross Profit | 139.31M |
| Operating Income | 67.00M |
| Pretax Income | 67.17M |
| Net Income | 34.23M |
| EBITDA | 156.36M |
| EBIT | 67.00M |
| Earnings Per Share (EPS) | 0.33 |
Balance Sheet
The company has 28.60 million in cash and 1.29 million in debt, with a net cash position of 27.31 million or 0.26 per share.
| Cash & Cash Equivalents | 28.60M |
| Total Debt | 1.29M |
| Net Cash | 27.31M |
| Net Cash Per Share | 0.26 |
| Equity (Book Value) | 2.42B |
| Book Value Per Share | 22.43 |
| Working Capital | 839.32M |
Cash Flow
In the last 12 months, operating cash flow was 73.19 million and capital expenditures -55.98 million, giving a free cash flow of 17.21 million.
| Operating Cash Flow | 73.19M |
| Capital Expenditures | -55.98M |
| Depreciation & Amortization | 89.35M |
| Net Borrowing | -4.86M |
| Free Cash Flow | 17.21M |
| FCF Per Share | 0.17 |
Margins
Gross margin is 34.09%, with operating and profit margins of 16.39% and 8.37%.
| Gross Margin | 34.09% |
| Operating Margin | 16.39% |
| Pretax Margin | 16.43% |
| Profit Margin | 8.37% |
| EBITDA Margin | 38.26% |
| EBIT Margin | 16.39% |
| FCF Margin | 4.21% |
Dividends & Yields
This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | 0.11 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 23.68% |
| Buyback Yield | -0.31% |
| Shareholder Yield | 0.21% |
| Earnings Yield | 1.59% |
| FCF Yield | 0.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 20, 2019. It was a forward split with a ratio of 1.1.
| Last Split Date | Nov 20, 2019 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |